Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Russell

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
Annals of Hematology|October 31, 2009
Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admissionSyed W I Bokhari, Talha Munir, Shabeeha Memon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant AlemtuzumabEmma P Das-Gupta, Nigel H Russell, Bronwen E Shaw, et al.
Experimental Hematology|September 4, 2007
A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapyFrancis H Grand, Sameena Iqbal, Lingyan Zhang, et al.
Blood|October 20, 2005
HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplantsBronwen E Shaw, Steven G E Marsh, Neema P Mayor, et al.
Immunology|September 13, 2002
Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responsesFrancesco Forconi, Catherine A King, Surinder S Sahota, et al.
British Journal of Haematology|March 30, 2007
Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi-disciplinary teams in the accurate staging and treatment of myeloma patientsJas Singh, K Julia Fairbairn, Catherine Williams, et al.
British Journal of Haematology|February 23, 2007
Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin diseaseMark J Bishton, Richard J Lush, Jenny L Byrne, et al.
British Journal of Haematology|December 7, 2018
Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adultsSylvie D Freeman, Robert K Hills, Nigel H Russell, et al.
Haematologica|July 2, 2013
Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvestRobert N Lown, Sameer Tulpule, Nigel H Russell, et al.
Leukemia Research|November 26, 2013
Distinct poor prognostic subgroups of acute myeloid leukaemia, FLT3-ITD and P-glycoprotein-positive, have contrasting levels of FOXO1Claire H Seedhouse, Ken I Mills, Sophie Ahluwalia, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Annals of Hematology|October 31, 2009
Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admissionSyed W I Bokhari, Talha Munir, Shabeeha Memon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant AlemtuzumabEmma P Das-Gupta, Nigel H Russell, Bronwen E Shaw, et al.
Experimental Hematology|September 4, 2007
A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapyFrancis H Grand, Sameena Iqbal, Lingyan Zhang, et al.
Blood|October 20, 2005
HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplantsBronwen E Shaw, Steven G E Marsh, Neema P Mayor, et al.
Immunology|September 13, 2002
Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responsesFrancesco Forconi, Catherine A King, Surinder S Sahota, et al.
British Journal of Haematology|March 30, 2007
Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi-disciplinary teams in the accurate staging and treatment of myeloma patientsJas Singh, K Julia Fairbairn, Catherine Williams, et al.
British Journal of Haematology|February 23, 2007
Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin diseaseMark J Bishton, Richard J Lush, Jenny L Byrne, et al.
British Journal of Haematology|December 7, 2018
Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adultsSylvie D Freeman, Robert K Hills, Nigel H Russell, et al.
Haematologica|July 2, 2013
Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvestRobert N Lown, Sameer Tulpule, Nigel H Russell, et al.
Leukemia Research|November 26, 2013
Distinct poor prognostic subgroups of acute myeloid leukaemia, FLT3-ITD and P-glycoprotein-positive, have contrasting levels of FOXO1Claire H Seedhouse, Ken I Mills, Sophie Ahluwalia, et al.
Pageof 12